ERICH6 Variant 1: Potential Drug Target and Neurodegenerative Diseases

Target Name: ERICH6

NCBI ID: G131831

ERICH6 Variant 1: Potential Drug Target and Neurodegenerative Diseases

ERICH6 (ERICH6 variant 1) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. Its full name is ERICH6, and it is a member of the ERICH6 family.

ERICH6 variant 1 is a protein with a molecular weight of 21.9 kDa. Its structure is slightly different from ERICH6 variant 2, but they both have conserved amino acid sequences.

ERICH6 variant 1 plays an important role in apoptosis, cell proliferation, cell migration, cell invasion and tumorigenesis. In tumorigenesis, the expression level of ERICH6 variant 1 usually increases with tumor growth.

Because ERICH6 variant 1 plays an important role in a variety of cancers, it is considered a potential drug target. Researchers are exploring ERICH6 variant 1 as a drug target to treat various cancers.

ERICH6 variant 1 also plays an important role in neurological diseases. For example, it has been linked to neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.

In addition, ERICH6 variant 1 is also associated with liver disease. The liver is an important metabolic organ in the human body and the main site of drug metabolism. Therefore, the expression level of ERICH6 variant 1 in liver diseases has received great attention.

ERICH6 variant 1 is a very important protein that plays an important role in maintaining human health. With the continuous development of science and technology, researchers will continue to explore the role of ERICH6 variant 1 in the treatment of various diseases.

Protein Name: Glutamate Rich 6

More Common Targets